Lanzamiento Enero 2027

Ensayo controlado aleatorizado2022Financiación no declaradaSolo mecanismos

Effects of supplementing a healthy diet with pecan nuts or extra-virgin olive oil on inflammatory profile of patients with stable coronary artery disease: a randomised clinical trial

Weschenfelder C, Gottschall CBA, Markoski MM, Portal VL, Quadros AS, Bersch-Ferreira ÂC, Marcadenti A

The British journal of nutrition · 14 citas

Etiquetas de revisión

Financiación no declaradaSolo mecanismos

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Solo mecanismos
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiación no declarada

Publicación

Publicado
2021-05-11 · Br J Nutr · vol. 127 · número 6 · págs. 862–871
Editorial
Cambridge University Press
Citado
15 citas · más que el 76% de estudios similares · 1.2× el promedio de su campo
Referencias
58 trabajos
Acceso
De pago
Áreas de investigación
Nuts composition and effects · Nutritional Studies and Diet · Fatty Acid Research and Health
Palabras clave
pecan nuts, extra virgin olive oil, stable coronary artery disease, inflammation, inflammatory markers, C-reactive protein, fibrinogen, interleukin-6, interferon-gamma, healthy eating, omega-3 fatty acids
MeSH
humans, carya, nuts, c-reactive protein, interleukin-6, coronary artery disease, biomarkers, olive oil, diet, healthy

7 autores

  • Camila Weschenfelder🇧🇷Fundação Universitária de Cardiologia
  • Catarina B.A. Gottschall🇧🇷Universidade Federal de Ciências da Saúde de Porto Alegre
  • Melissa Medeiros Markoski🇧🇷Universidade Federal de Ciências da Saúde de Porto Alegre
  • Vera Lúcia Portal🇧🇷Fundação Universitária de Cardiologia
  • Alexandre S. de Quadros🇧🇷Fundação Universitária de Cardiologia
  • Ângela Cristine Bersch-Ferreira🇧🇷Hospital do Coração
  • Aline Marcadenti🇧🇷 · autor de correspondenciaFundação Universitária de Cardiologia; Hospital do Coração

Resumen

El texto original del estudio, en el idioma en que se publicó.

The consumption of nuts and extra-virgin olive oil has been associated with suppression of inflammatory pathways that contribute to atherosclerosis, but its role on the modulation of the inflammatory profile in patients with established coronary artery disease (CAD) is unclear. The aim of this study was to evaluate the effects of adding pecan nuts or extra-virgin olive oil to a healthy diet on inflammatory markers in patients with stable CAD. In this randomised clinical trial, 204 patients were enrolled to three study groups: sixty seven to control group (CG: healthy diet), sixty eight to pecan nuts group (PNG: 30 g/d of pecans + healthy diet) and sixty nine to extra-virgin olive oil group (OOG: 30 ml/d of extra-virgin olive oil + healthy diet). High-sensitivity C-reactive protein (hs-CRP, in mg/l), fibrinogen (mg/dl), IL 2, 4, 6, 10 (pg/ml) and interferon-γ (IFN-γ, in pg/ml), IL-6/IL-10, IL-2/IL-4 and IFN-/γIL-4 ratios were evaluated at baseline and after the follow-up (12 weeks). As main results, after adjustment for sex, statin used and relative body weight variation, there were no differences between groups regarding inflammatory markers at the end of the study. IL-6 levels (primary outcome) were reduced in 12 weeks when compared with baseline in all study groups (CG: difference: -0·593 (se = 0·159) pg/dL; PNG: difference: -0·335 (se = 0·143) pg/dl; OOG: IL-6 difference: -0·325 (se = 0·143) pg/dl). In conclusion, there was no significant effect of including pecan nuts or extra virgin olive oil to a healthy diet on inflammatory markers in individuals with CAD.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.